BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34799743)

  • 21. Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study.
    Mangili G; Sigismondi C; Frigerio L; Candiani M; Savarese A; Giorda G; Lauria R; Tamberi S; Greggi S; Lorusso D
    Gynecol Oncol; 2013 Jul; 130(1):38-42. PubMed ID: 23623833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
    Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
    Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological outcome of ovarian granulosa cell tumors.
    Al-Rayyan E; Maaita M; Alelwan O; Taso O; Hadadin W
    Gulf J Oncolog; 2018 Sep; 1(28):31-36. PubMed ID: 30344131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stromal p16 Overexpression in Adult Granulosa Cell Tumors of the Ovary.
    Na K; Sung JY; Kim HS
    Anticancer Res; 2017 May; 37(5):2437-2444. PubMed ID: 28476811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of adult granulosa cell tumor of the ovary: experience at a tertiary care center.
    Ud Din N; Kayani N
    Ann Diagn Pathol; 2014 Jun; 18(3):125-8. PubMed ID: 24630126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term follow-up of a large series of stage-II/III atypical proliferative serous ovarian tumors.
    Maria S; Faron M; Maulard A; Pautier P; Leary A; Chargari C; Genestie C; Gouy S; Morice P
    Gynecol Oncol; 2020 Sep; 158(3):659-665. PubMed ID: 32571680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Outcomes and Prognostic Factors after Fertility-Sparing Surgery in Patients with Early Stage Juvenile Granulosa Cell Tumor of the Ovary: Experience from a Tertiary Center.
    Wang D; Jia C; Cheng H; Cao D; Shen K; Yang J; Xiang Y
    J Pediatr Adolesc Gynecol; 2022 Aug; 35(4):486-491. PubMed ID: 34902562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic predictors and spread patterns in adult ovarian granulosa cell tumors: a multicenter long-term follow-up study of 108 patients.
    Ertas IE; Gungorduk K; Taskin S; Akman L; Ozdemir A; Goklu R; Terek MC; Ozsaran A; Dikmen Y; Yildirim Y; Ortac F
    Int J Clin Oncol; 2014 Oct; 19(5):912-20. PubMed ID: 24162502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian granulosa cell tumors: a retrospective study of 27 cases and a review of the literature.
    Sekkate S; Kairouani M; Serji B; Tazi A; Mrabti H; Boutayeb S; Errihani H
    World J Surg Oncol; 2013 Jun; 11():142. PubMed ID: 23777285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Granulosa-cell tumor of the ovary: report of 16 cases].
    Ellouze S; Krichen-Makni S; Trabelsi K; Ayadi L; Sellami A; Khabir A; Hammami S; Mnif H; Sellami-Boudawara T
    J Gynecol Obstet Biol Reprod (Paris); 2006 Dec; 35(8 Pt 1):767-72. PubMed ID: 17151531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The prognostic factors in patients with malignant granulosa-theca cell tumors of the ovaries].
    Adamian RT
    Vopr Onkol; 1991; 37(9-10):985-8. PubMed ID: 1668808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
    Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
    Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
    Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
    Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence of granulosa cell tumor 25 years after initial diagnosis. Report of a case and review of the literature.
    Hasiakos D; Papakonstantinou K; Karvouni E; Fotiou S
    Eur J Gynaecol Oncol; 2008; 29(1):86-8. PubMed ID: 18386473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study.
    Mangili G; Ottolina J; Cormio G; Loizzi V; De Iaco P; Pellegrini DA; Candiani M; Giorda G; Scarfone G; Cecere SC; Frigerio L; Gadducci A; Marchetti C; Ferrandina G
    Gynecol Oncol; 2016 Nov; 143(2):276-280. PubMed ID: 27597380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical aspects and prognosis of granulosa cell tumors of the ovary].
    Scharl A; Vierbuchen M; Kusche M; Bolte A
    Geburtshilfe Frauenheilkd; 1988 Aug; 48(8):567-73. PubMed ID: 3215451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulosa Cell Tumor of the Ovary: A Retrospective Study of 31 Cases and a Review of the Literature.
    Dridi M; Chraiet N; Batti R; Ayadi M; Mokrani A; Meddeb K; Yahiaoui Y; Raies H; Mezlini A
    Int J Surg Oncol; 2018; 2018():4547892. PubMed ID: 29796312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and paraclinical features, outcome, and prognosis of ovarian granulosa cell tumor: A retrospective study of 28 Vietnamese women.
    Le DT; Do TA; Nguyen LLT; Do KH; Van Nguyen C
    Rare Tumors; 2022; 14():20363613221148547. PubMed ID: 36582403
    [No Abstract]   [Full Text] [Related]  

  • 40. Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study.
    Bergamini A; Ferrandina G; Candiani M; Cormio G; Giorda G; Lauria R; Perrone AM; Scarfone G; Breda E; Savarese A; Frigerio L; Gadducci A; Mascilini F; Maneschi F; Cassani C; Marchetti C; Cecere SC; Biglia N; De Giorgi U; Raspagliesi F; Lorusso D; Mangili G
    Eur J Surg Oncol; 2018 Jun; 44(6):766-770. PubMed ID: 29576462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.